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The PFO Gets Blamed
Again.Perhaps This
Time it Is Real*Alfred A. Bove, MD, PHD
Philadelphia, Pennsylvania
Patent foramen ovale (PFO) closure is the thing to do these
days in the interventional laboratory. Closures are done
for strokes, migraine headaches, and postural cyanosis, and
for divers who are at risk for decompression sickness. Atrial
septal defect closures are also done in the interventional
laboratory, but these are known to reduce the signiﬁcant
left-to-right intracardiac shunt that eventually, when large
enough, results in pulmonary hypertension, an Eisenmenger
syndrome, and permanent lung injury. We have seen the
image of a thrombus partially protruding through the PFO,
threatening a major stroke (1), and seen the retrospective
data indicating that there is a higher incidence of PFOs
in patients with cryptogenic strokes, and in some forms
of decompression sickness (2). But, the Reverend Bayes
continually reminds us that an increased incidence of PFO
in a stroke population is not the same as an increased
incidence of stroke in a PFO population, particularly with
the high incidence of PFO in the general population (3)
or, in Bayesian terms, the high prior probability of PFOSee page 403presence. Prospective randomized clinical trials of PFO
closure for cryptogenic stroke have to date been disap-
pointing in that they have not demonstrated a reduced
stroke rate after closure (4,5), and the value of PFO closure
for relieving migraine headaches has also been inconclusive
(6). Similar concerns regarding the role of a PFO in
decompression sickness have been a topic of discussion in
altitude (7), space (8), and undersea exposures (9,10). All of
these environments commonly produce venous gas emboli
(VGE) from supersaturated nitrogen dissolved in blood and
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aviators ﬂying at high altitude, and divers returning from
underwater exposures all experience this risk, and under
circumstances of high degrees of supersaturation, will
demonstrate VGE and, eventually, clinical evidence of
decompression sickness (DCS) (13,14). The syndrome of
DCS has been described for over 100 years (11,12), and the
circumstances that result in DCS are well understood.
Protocols for minimizing risk and prevention are well
accepted; indeed, most sport divers now carry decompres-
sion computers on their wrist while diving to aid in safe
decompression (15). Yet, there remains some unpredict-
ability in DCS, and the question of whether a PFO con-
tributes to DCS has been debated. Studies so far have been
inconclusive, but as in stroke and migraine, a higher than
expected incidence of PFO has been noted in divers with
unexplained DCS (2), and a Bayesian meta-analysis suggests
that a PFO does increase risk for DCS (16). Torti et al. (17)
observed an increased incidence of DCS in divers with large
PFOs compared with those with small or no shunt. Ger-
monpré et al. (18) found an increased incidence of large
PFOs in divers with evidence of diving-related cerebral
injury compared with symptom-free divers with similar ex-
posures, and the work of Billinger et al. (19) showed mag-
netic resonance imaging bright objects in divers with a PFO.
In this issue of JACC: Cardiovascular Interventions,
Honek et al. (20) report an important study that helps
elucidate the relationship between PFO and DCS. They
exposed a group of sport divers to 2 acceptable (though
risky) depth-time exposures and found a very high occur-
rence of VGE in the divers. These exposures are not rec-
ommended for sport diving by most diving organizations
around the world, but are commonly followed by com-
mercial divers, and recently by extension of sport diving
to “technical diving,” where exposures to deeper depths,
special gas mixtures, and need for staged decompression
procedures all increase risk for DCS. Honek et al. (20)
focused their study on divers found to have a large PFO
who had previously experienced DCS symptoms when
diving. A comparator group of divers without a PFO or
with a small PFO was found to have a low incidence of
DCS. As expected, the VGE were found to arterialize in
the presence of a large PFO. Their detection method
(transcranial Doppler) detected arterial bubbles signals in
32% of 18-m divers without closure and 0% of divers with
closure of the PFO, and in 88% of the 50-m divers without
closure and 0% of such divers with PFO closure. These
exposures actually caused clinical evidence of neurological
DCS in 20% to 25% of divers with an unclosed PFO and
0% of divers who had their PFO closed. Although the
frequency of arterial gas emboli (AGE) was signiﬁcantly
reduced (p ¼ 0.02) with PFO closure, the reduction of
DCS incidence did not reach statistical signiﬁcance
(p ¼ 0.11 for the 18-m dive and p ¼ 0.49 for the 50-m
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410dive). Yet, these data are compelling. Experienced dive
supervisors have known for many years that a 50-m dive for
20 min using compressed air as the breathing gas results in
an increased incidence of DCS even when the proper
decompression schedules are observed, and as a result, often
extend the decompression time to lower the DCS incidence
(personal observation). One could speculate that a 10% to
15% incidence of DCS following this exposure occurred in
the 10% to 15% of divers who had a large PFO. Similarly,
the 18-m exposure for 80 min requires staged decompres-
sion (21,22) and increases the risk for DCS.
The study by Honek et al. (20) provides several important
observations. They demonstrated that diving exposures
requiring staged decompression are likely to produce a high
incidence of VGE that will become AGE in the presence
of a large PFO. This ﬁnding supports the recommendations
for sport diving that depth should not exceed 130 feet
(40 m), and exposure time should be limited to avoid staged
decompression (no-decompression diving). They also de-
monstrate that closing the PFO eliminates the arterialization
of VGE. However, their data do not conﬁrm that closure
will reduce the incidence of DCS. We know that AGE from
pulmonary barotrauma (23) or iatrogenic AGE (24) can
result in profound neurological injury, and logic would lead
to the conclusion that AGE resulting from a large venous
bubble load in the presence of a large PFO would result in
neurological symptoms of DCS.
Their study would have beneﬁtted from a similar exposure
of divers with a small or no PFO for a true control group.
However, a large, prospective, randomized clinical trial
is unlikely to be supported to obtain a deﬁnitive answer
regardingDCS and PFO closure. Importantly, one should not
conclude that commercial and technical divers who are exposed
to risky dive proﬁles be screened for a PFO or have a PFO
closed prophylactically, but commercial divers who have
multiple recurrences of unexplained DCS should be screened
for a PFO, and if found, a decision to close the shunt should be
made by the diver and physician together, depending on career
goals, work requirements, and risk of complications of the
closure procedure. Sport and technical divers who have expe-
rienced a DCS event with or without a PFO should be advised
to reduce risk by limiting depth and time to safe exposures.
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